TXO TXO Q1 2026 Miss Should Investors Be Worried AI Industry Emerges as Key Beneficiary in MuskAltman Legal Battle Intellinetics Holds Steady at 670 as Key Levels Define Trading Range Live Nation Entertainment Inc LYV Mark Cubans Strategic Bet on Live Entertainment Returns LSEG Reports Income Growth Driven by Tradeweb Performance US Fuel Prices May Not Normalize This Year Even If Iran Conflict Ends Analysis Suggests Wall Street Analysts Weigh In on Air Products and Chemicals Stock Goldman Sachs Reportedly Selected to Lead SpaceX IPO in Potential Landmark Market Debut AI Infrastructure and Energy Basket May Outperform Nvidia Market Data Suggests Consumer Sentiment Hits Record Low in May Amid Iran Conflict and Rising Oil Prices SEE Q4 2025 Earnings EPS Beats Estimates on Operational Strength TLK Q4 2025 Earnings Significant EPS Miss Sends Shares Lower MKTW Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Rises 2 DECK Q1 2026 Earnings EPS Surpasses Estimates by 1337 INTT Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution Lightspeed Commerce Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Nucor Corporation NUE Gains 36 as Steel Sector Momentum Builds BlackRock Science and Technology Term Trust BSTZ Rises 113 as Tech Sentiment Improves Roman DBDR Acquisition Corp II Warrants DRDBW Slide 1157 as Price Nears Support Level Liberty Broadband Preferred LBRDP Edges Higher as YieldSeekers Refocus Definium Therapeutics DFTX Retreats Marginally as Key Support Holds at 2138 New Found Gold Corp NFGC Surges 556 Testing Key Resistance at 21 Immatics IMTX Surges 5 Breaking Resistance or Facing a Ceiling Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus Emerson Electric EMR Edges Higher as Industrial Sector Fundamentals Show Resilience Banco Latinoamericano de Comercio Exterior BLX Slips 227 Key Support and Resistance in Focus AI Stocks Plunge as DeepSeek Sparks Broad Market Selloff BUSE Q1 2026 Earnings Strong EPS Beat Drives Optimism Vera Therapeutics VERA Consolidates Near Support After Slight Decline